Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-295,980
Closed -$429K 2660
2025
Q3
$429K Sell
295,980
-2,570
-0.9% -$4.72K ﹤0.01% 1824
2025
Q2
$770K Buy
298,550
+146,700
+97% +$332K ﹤0.01% 1553
2025
Q1
$334K Buy
151,850
+30,800
+25% +$201K ﹤0.01% 1948
2024
Q4
$970K Sell
121,050
-5,000
-4% -$41.2K ﹤0.01% 1473
2024
Q3
$1.03M Sell
126,050
-84,000
-40% -$708K ﹤0.01% 1398
2024
Q2
$1.96M Buy
210,050
+8,900
+4% +$94.7K ﹤0.01% 1205
2024
Q1
$2.49M Buy
201,150
+51,500
+34% +$618K 0.01% 1109
2023
Q4
$1.63M Buy
149,650
+17,540
+13% +$156K ﹤0.01% 1400
2023
Q3
$1.06M Buy
+132,110
New +$1.11M ﹤0.01% 1497

Other funds holding ZYXI

Two Sigma Advisers's ZYXI Position: Q4 2025 in Review

Two Sigma Advisers sold out of Zynex (ZYXI) in Q4 2025, closing a stake of 295,980 shares — an estimated $429K sold.

Two Sigma Advisers first reported a position in ZYXI in Q3 2023 and held it in 9 quarters. The position peaked at $2.49M in Q1 2024. 5 funds tracked by Wall St. Rank hold ZYXI as of Q4 2025.

  • Two Sigma Advisers reported no remaining Zynex position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 295,980 Zynex shares in Q4 2025, an estimated $429K.
  • Two Sigma Advisers first reported a position in Zynex in Q3 2023 and held it in 9 quarters.
  • Two Sigma Advisers's Zynex position peaked at $2.49M in Q1 2024.
  • 5 funds tracked by Wall St. Rank held Zynex as of Q4 2025.

Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.